Parnassin, a Novel Therapeutic Peptide, Alleviates Skin Lesions in a DNCB-Induced Atopic Dermatitis Mouse Model

Atopic dermatitis (AD) is a chronic inflammatory skin disease which requires continuous treatment due to its relapsing nature. The current treatment includes steroids and nonsteroidal agents targeting inflammation but long-term administration causes various side effects such as skin atrophy, hirsuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang-Bo, Jeon, Veerappan, Karpagam, Moon, Hyunhye, Lee, Tae-Hoon, Lee, Kang-Woon, Park, Junhyung, Chung, Hoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216559/
https://www.ncbi.nlm.nih.gov/pubmed/37239060
http://dx.doi.org/10.3390/biomedicines11051389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216559/
https://www.ncbi.nlm.nih.gov/pubmed/37239060
http://dx.doi.org/10.3390/biomedicines11051389

Ejemplares similares